Related Experiment Video
Updated: Oct 10, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
Clinical features of children with coronavirus disease 2019 caused by Delta variant infection
Jun-Feng Sheng1, Lan Shao1, Yu-Lin Wang1
1Department of Pediatrics, First People's Hospital of Jingmen, Jingmen, Hubei 448000, China.
Insights
The Delta variant of COVID-19 is more infectious in children than the original strain. Delta variant infections may lead to more severe heart damage, with similar antibody responses observed.
Area of Science:
- Pediatrics
- Infectious Diseases
- Virology
Background:
- The emergence of the SARS-CoV-2 Delta variant presented new challenges in understanding its impact on pediatric populations.
- Previous studies have focused on adult populations, leaving a gap in knowledge regarding the specific clinical and epidemiological features of COVID-19 in children infected with the Delta variant.
Purpose of the Study:
- To investigate the epidemiological and clinical characteristics of COVID-19 in children caused by the Delta variant.
- To compare these features with those of children infected with non-Delta variants of SARS-CoV-2.
Main Methods:
- A comparative study involving two groups of children under 14 years old.
- The variant group (n=11) was diagnosed with Delta variant COVID-19 (August-September 2021).
- The control group (n=5) was diagnosed with ordinary COVID-19 (February-March 2020).
- Epidemiological data, clinical symptoms, and laboratory results were analyzed and compared.
Main Results:
- No significant difference in the proportion of children with clinical symptoms between the Delta variant and control groups.
- The Delta variant group showed a lower neutrophil count but no significant differences in white blood cell count, lymphocyte count, or platelet count compared to the control group.
- A higher proportion of children in the Delta variant group exhibited elevated creatine kinase isoenzyme, suggesting potential myocardial damage, while other inflammatory markers showed no significant differences.
- Antibody response: IgM and IgG antibodies were detected in children with Delta variant infection, with IgG appearing concurrently with IgM.
Conclusions:
- The Delta variant demonstrates increased infectiousness in pediatric populations.
- COVID-19 caused by the Delta variant may be associated with more severe myocardial damage in children compared to non-Delta variants.
- In children infected with the Delta variant, IgG antibody development occurs around the same time as IgM antibody development.
Objectives:
To study the epidemiological and clinical features of children with coronavirus disease 2019 (COVID-19) caused by Delta variant infection and their differences from children with ordinary COVID-19 (non-Delta variant infection).
Methods:
Eleven children aged <14 years, who were diagnosed with COVID-19 caused by Delta variant infection from August to September 2021 were enrolled (variant group). Five children aged <14 years who were diagnosed with ordinary COVID-19 from February to March 2020 served as the control group. The epidemiological data, clinical features, and laboratory examination results were compared between the two groups.
Results:
There was no significant difference in the proportion of children with clinical symptoms between the two groups (P>0.05). There were no significant differences in white blood cell count, lymphocyte count, and platelet count between the two groups (P>0.05), while the variant group had a lower neutrophil count than the control group (P<0.05). Lymphocytopenia was not observed in either group. Compared with the control group, the variant group had a higher proportion of children with an increase in creatine kinase isoenzyme (P<0.05), while there were no significant differences in the proportion of children with an increase in lactate dehydrogenase, D-Dimer, C-reactive protein or interleukin-6 between the two groups (P>0.05). Among the 9 children in the variant group, 5 tested positive for IgM antibody at week 2 after admission, and all children tested positive for IgG antibody. At week 3 after admission, the level of IgM antibody tended to decrease in 9 children, and the level of IgG antibody tended to decrease in 8 children.
Conclusions:
Delta variant is more infectious. COVID-19 caused by Delta variant infection may cause more serious myocardial damage than ordinary COVID-19 in children. In children infected with Delta variant, IgG antibody appears at almost the same time as IgM antibody.
More Related Videos
09:03Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
08:05Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
Related Concept Videos
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Endocarditis II: Clinical Features of Infective Endocarditis
Conduct Disorder
Myocarditis II: Clinical Features and Diagnostic Tests
Oppositional Defiant Disorder
Diagnostic Criteria and...
Pulmonary Cycle: Exhalation